Morgan Stanley’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-919
| Closed | -$35.8K | – | 8068 |
|
2024
Q2 | $35.8K | Sell |
919
-5,067
| -85% | -$198K | ﹤0.01% | 6271 |
|
2024
Q1 | $126K | Buy |
5,986
+4,782
| +397% | +$100K | ﹤0.01% | 5898 |
|
2023
Q4 | $31K | Sell |
1,204
-1,124
| -48% | -$28.9K | ﹤0.01% | 6516 |
|
2023
Q3 | $42.5K | Sell |
2,328
-328
| -12% | -$5.99K | ﹤0.01% | 6235 |
|
2023
Q2 | $42.1K | Buy |
2,656
+1,269
| +91% | +$20.1K | ﹤0.01% | 6277 |
|
2023
Q1 | $33.2K | Sell |
1,387
-51
| -4% | -$1.22K | ﹤0.01% | 6438 |
|
2022
Q4 | $24.4K | Buy |
1,438
+305
| +27% | +$5.19K | ﹤0.01% | 6601 |
|
2022
Q3 | $18K | Sell |
1,133
-3,162
| -74% | -$50.2K | ﹤0.01% | 6844 |
|
2022
Q2 | $76K | Buy |
4,295
+3,566
| +489% | +$63.1K | ﹤0.01% | 6412 |
|
2022
Q1 | $14K | Sell |
729
-2,026
| -74% | -$38.9K | ﹤0.01% | 7293 |
|
2021
Q4 | $69K | Buy |
2,755
+750
| +37% | +$18.8K | ﹤0.01% | 6648 |
|
2021
Q3 | $43K | Buy |
2,005
+992
| +98% | +$21.3K | ﹤0.01% | 6792 |
|
2021
Q2 | $30K | Buy |
1,013
+317
| +46% | +$9.39K | ﹤0.01% | 6863 |
|
2021
Q1 | $19K | Buy |
+696
| New | +$19K | ﹤0.01% | 6739 |
|
2020
Q3 | – | Sell |
-69
| Closed | -$2K | – | 6858 |
|
2020
Q2 | $2K | Buy |
+69
| New | +$2K | ﹤0.01% | 6471 |
|